Clinical Trial Update: Erlotinib Versus Carboplatin/Vinorelbine in Elderly Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing erlotinib to carboplatin/vinorelbine in elderly patients with advanced non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Tarceva (erlotinib)
• Vinorelbine (Vinorelbine)

Snippet

Sponsor: LungenClinic Grosshansdorf | Conditions: Non-Small Cell Lung Cancer | Phase 2 | Status: UNKNOWN